ArticleFrontiers in pharmacology2021

Spironolactone Improves the All-Cause Mortality and Re-Hospitalization Rates in Acute Myocardial Infarction with Chronic Kidney Disease Patients.

Xiang Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.